Vitale Vaten set of clinical indicators
| Clinical indicators | Origin | |
| 1 | Percentage of patients with established CVD with a record of smoking status | UniRap |
| 2 | Percentage of patients with established CVD with anticoagulant or antiplatelet drugs prescribed | UniRap |
| 3 | Percentage of patients with established CVD in the practice population at the end of the reporting period (denominator is the practice population) | UniRap |
| 4 | For patients with CVD (CHD, stroke, TIA or PVD) there is a record of smoking status in the past 15 months except those who never smoked | EPA Cardio |
| 5 | For patients with diabetes there is a record of blood pressure at least once in the last 15 months | EPA Cardio |
| 6 | For patients prescribed antihypertensive medication for diagnosed hypertension there is a record of blood pressure at least once in the last 15 months | EPA Cardio |
| 7 | For patients with established CVD (CHD, stroke, TIA or PVD) there is a record of blood pressure at least once in the last 15 months | EPA Cardio |
| 8 | For patients with diabetes there is a record of their cholesterol (general/total, high-density lipoprotein and low-density lipoprotein) at least once in the last 15 months | EPA Cardio |
| 9 | For patients with CVD (CHD, stroke, TIA or PVD), there is a record that antiplatelet therapy (aspirin, clopidogrel or equivalent) at least 75 mg daily has been offered unless contraindicated | EPA Cardio |
| 10 | CVD risk assessment includes smoking status | EPA Cardio |
| 11 | CVD risk assessment includes blood pressure | EPA Cardio |
| 12 | CVD risk assessment includes personal history of diabetes | EPA Cardio |
| 13 | For patients with CVD, blood plasma glucose is tested at diagnosis | EPA Cardio |
| 14 | For patients with diabetes, there is a record of smoking status in the past 15 months except for those who have never smoked whose smoking status should be recorded at least once | EPA Cardio |
| 15 | For patients with diabetes, there is a record of their weight or body mass index at least once in the last 15 months | EPA Cardio |
| 16 | For patients with CVD (CHD, stroke, TIA or PVD), there is a record of their weight or body mass index at least once in the last 15 months | EPA Cardio |
| 17 | For patients with diabetes, there is a record that diet advice has been offered at least once in the last 15 months | EPA Cardio |
| 18 | For patients with CVD (CHD, stroke, TIA or PVD), there is a record of their cholesterol (general/total, HDL and LDL) at least once in the last 15 months | EPA Cardio |
| 19 | All patients with CVD (CHD, stroke, TIA or PVD) should have their systolic blood pressure controlled to <140 | EPA Cardio |
| 20 | All patients with CVD (CHD, stroke, TIA or PVD) are offered a statin | EPA Cardio |
| 21 | For patients who have had a myocardial infarction, there is a record that a β blocker has been offered (unless a contraindication or side-effects are recorded) | EPA Cardio |
| 22 | CVD risk assessment includes age | EPA Cardio |
| 23 | CVD risk assessment includes gender | EPA Cardio |
| 24 | CVD risk assessment includes diabetes status | EPA Cardio |
| 25 | For patients with diabetes, there is a record that specific advice about lifestyle was offered at least once in the last 5 years | EPA Cardio |
CHD, coronary heart disease; CVD, cardiovascular disease; PVD, peripheral vascular disease; TIA, transient ischaemic attack.